retinoic acid receptor — Drug Target

All drugs that target retinoic acid receptor — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

retinoid · Retinoid · topical retinoid

Phase 3 pipeline (6)

• Tazarotene Foam · Stiefel, a GSK Company · retinoid · Dermatology
  Tazarotene Foam is a topical retinoid that modulates cell growth and differentiation.
• Tazarotene (Fabior™) · Actavis Inc. · retinoid · Dermatology
  Tazarotene is a topical retinoid that modulates the expression of genes involved in cell proliferation and differentiation.
• Tazarotene Cream 0.05% · Fougera Pharmaceuticals Inc. · retinoid · Dermatology
  Tazarotene is a topical retinoid that modulates cell growth and differentiation.
• NIK-333(peretinoin) · Kowa Company, Ltd. · retinoid · Oncology
  NIK-333 (peretinoin) is a synthetic retinoid that acts as a retinoic acid receptor agonist.
• adapalene lotion 0.1% · Galderma R&D · Retinoid · Dermatology
  Adapalene is a topical retinoid that works by binding to retinoic acid receptors, modulating gene expression and promoting cell turnover.
• QM1114-DP · Galderma R&D · topical retinoid · Dermatology
  QM1114-DP is a topical treatment that targets the inflammatory pathways in the skin.

Phase 2 pipeline (2)

• CD1579 5% · Galderma R&D · retinoid · Dermatology
  CD1579 5% is a topical retinoid that modulates cell growth and differentiation.
• Fenretinide Lym-X-Sorb Oral Powder · South Plains Oncology Consortium · retinoid · Oncology
  Fenretinide is a synthetic retinoid that induces apoptosis in cancer cells.